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Stem cells are characterized by two defining features, the ability to self-renew and to differentiate into highly specialized cell
types. The POU homeodomain transcription factor Oct4 (Pou5f1) is an essential mediator of the embryonic stem cell state and
has been implicated in lineage specific differentiation, adult stem cell identity, and cancer. Recent description of the regulatory
networks which maintain ‘ES’ have highlighted a dual role for Oct4 in the transcriptional activation of genes required to
maintain self-renewal and pluripotency while concomitantly repressing genes which facilitate lineage specific differentiation.
However, the molecular mechanism by which Oct4 mediates differential activation or repression at these loci to either
maintain stem cell identity or facilitate the emergence of alternate transcriptional programs required for the realization of
lineage remains to be elucidated. To further investigate Oct4 function, we employed gene expression profiling together with
a robust statistical analysis to identify genes highly correlated to Oct4. Gene Ontology analysis to categorize overrepresented
genes has led to the identification of themes which may prove essential to stem cell identity, including chromatin structure,
nuclear architecture, cell cycle control, DNA repair, and apoptosis. Our experiments have identified previously unappreciated
roles for Oct4 for firstly, regulating chromatin structure in a state consistent with self-renewal and pluripotency, and secondly,
facilitating the expression of genes that keeps the cell poised to respond to cues that lead to differentiation. Together, these
data define the mechanism by which Oct4 orchestrates cellular regulatory pathways to enforce the stem cell state and
provides important insight into stem cell function and cancer.
Citation: Campbell PA, Perez-Iratxeta C, Andrade-Navarro MA, Rudnicki MA (2007) Oct4 Targets Regulatory Nodes to Modulate Stem Cell
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INTRODUCTION
Embryonic Stem Cells (ESCs) are derived from the inner cell mass
of the pre-implantation embryo and are characterized by their
unlimited capacity for self-renewal and their ability to contribute
to all cell lineages. The successful derivation and culture of human
ESCs (hESCs) [1] has opened the possibility of their use for
generating cells for transplant, for tissue engineering or for drug
development and testing. Importantly, full exploitation of the
potential of hESCs will require the complete understanding of the
function of the genetic factors that specify stem cell identity and
regulate their commitment towards specific differentiated cell
lineages. However, the transcriptional networks and molecular
mechanisms that regulate the formation, self-renewal, and
differentiation of hESC and mouse ESC (mESC) remain at best
poorly understood.
Oct4 (Pou5f1), a POU-homeodomain transcription factor, plays
a central role in self-renewal, pluripotency, and lineage commit-
ment. Initially expressed as a maternal transcript, Oct4 is required
for the formation of a pluripotent inner cell mass [2]. Moreover,
strict control of Oct4 expression is necessary to maintain ESC
identity. Alterations in Oct4 expression promote differentiation
and leads to the specification of ectodermal [3], endodermal [4],
or mesodermal [5] primitive progenitors. Furthermore, Oct4 has
been shown to promote tumor growth in a dose dependent
manner [6] and epithelial dysplasia by interfering with progenitor
cell differentiation [7], is expressed in various human tumors [8,9]
and adult stem cells [10] thus extending the role of Oct4 from
embryo to adult.
Recent identification of Oct4 transcriptional targets in ESCs has
revealed an unanticipated collaboration between Oct4, Sox2, and
Nanog and provides a starting framework of the core transcrip-
tional circuitry which maintains ‘ES’ through coordination of
a series of feedback and feedforward loops [11,12]. Furthermore,
several signaling pathways including LIF/JAK/STAT, BMP,
WNT, PI3K, MAPK/ERK, TGFb and Notch [13,14,15,16] have
been shown to modulate stem cell function. Several key questions
however still remain unresolved as a result of these studies. Firstly,
what are the regulatory mechanisms that maintain self-renewal
and pluripotency? Conversely, what are the molecular inputs that
drive differentiation? Finally, and most importantly, can we
deduce the essential themes that characterize stem cell function
and thereby utilize this knowledge to gain insight into normal
developmental processes to predict the consequences of aberra-
tions to these processes that ultimately lead to human disease?
To address these questions and further elucidate the factors that
mediate stem cell function, we undertook an analysis to identify
genes whose expression is correlated to Oct4. With the un-
derstanding that coexpression of genes may imply coregulation
and participation in similar biological processes [17], we sought to
identify genes which were correlated to Oct4 transcript expression
in a wide variety of stem/progenitor populations which were
analyzed by Affymetrix GeneChip technology as part of the Stem
Cell Genomics Project [18]. We hypothesized that by using Oct4
as a marker gene for self-renewal, pluripotency, and early lineage
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Genes that are central to stem cell identity; 2) Oct4 target genes;
and 3) Genes that modulate Oct4 function. Although several
previous studies have sought to harmonize our understanding of
‘stemness’ [19,20] it has been suggested that rather than the
capacity for self-renewal and differentiation, the unique defining
feature of a stem cell is that it represents a lasting steady-state of
gene expression suspended in its differentiation pathway, yet
maintaining the ability to respond to niche induced signals to carry
out the indicated program of cellular specialization [21]. Insight
into the juncture between cell extrinsic and intrinsic factors
described above will provide an enhanced understanding of the
molecular mechanisms which confer stem cells with this ability.
Lineage commitment can be described as a process whereby the
unlimited ability for self-renewal and potency are gradually
restricted as a cell progresses from one steady state of gene
expression to the next. Recently attributed to stochastic events
which increase the likelihood of a specific developmental outcome
[22], this view is in direct opposition to determinism, which
precludes the processing of molecular cues emanating from the
cellular niche. In juxtaposition to both the stochastic and
deterministic models of development is the view that cellular
commitment is facilitated by a hierarchy of transcriptional
regulatory networks [23] which exert precise biological control
by combinatorial interactions at the protein-protein, and protein-
DNA level. The function of these networks is highly responsive to
molecular inputs, allowing the rapid processing and relay of
information required for either maintenance of a specific cellular
state, or progression to an altered steady state. Importantly, our
data suggests that Oct4 maintains stem cell identity by targeting
key regulatory genes which play critical roles in determining cell
fate.
RESULTS AND DISCUSSION
Oct4 Correlation Analysis
A set of 45 murine samples collected as part of the Stem Cell Genomics
Project and deposited in StemBase (http://www.StemBase.ca/)
[18] were selected to form the basis of this analysis (Supplemental
Table S1 ). A wide variety of samples comprising adult and
embryonic stem cells and their differentiated derivatives were
collected in biological triplicate and hybridized to the Affymetrix
MOE430 GeneChip Set for a total of 270 GeneChips. Following
normalization, scaling, and filtering of the data the standard
Pearson correlation coefficient (rho) between every probeset which
passed the filter, to the Oct4 probeset was computed. A probeset was
considered correlated to Oct4 if |rho|$0.75. This computation was
repeated 10,000 times with random subsets consisting of 65% to
70% of the data. Probesets that were correlated to the Oct4
associated probe in at least 40% of the trials were retained for
further analysis (Supplemental Table S2).
The stringency of our correlation analysis is set by two
parameters; |rho|$0.75 and the percentage of trials in which
this value for rho is met or exceeded. In setting these parameters
our aim was to prioritize genes for analysis which may have either
represented Oct4 targets or genes which were implicated in self-
renewal, pluripotency, or early lineage commitment. The values
were pragmatic in nature; chosen as such to produce a reasonable
number of genes which could be analyzed in a coherent fashion,
possibly being able to provide a snapshot as it were of ‘stemness’.
The use of more or less stringent parameters would result in the
identification of fewer or more genes. Of note, cursory
examination of the cutoffs used reveals that should we have
increased the percentage of trials for which |rho|$0.75 from 40%
to 50% we would not have identified at least two previously
identified Oct4 targets; Sox2 (49%) and Cdyl (40%) [11,12].
As a result of this analysis 1299 probesets (1155 unique
transcripts) were found to be correlated to Oct4. Seventy-five
probesets (69 transcripts) were negatively correlated, while 1224
probesets (1086 transcripts) were positively correlated. The
validity of this method for the identification of genes related to
stem cell identity is assured by the presence of genes which have
previously defined roles in ESCs such as Utf1, Fgf4, Nanog,a n d
Sox2 which were correlated to Oct4 in 100%, 99%, 97% and
49% of the trials respectively. Comparison of the transcript
expression levels of Oct4 and correlated Nanog, Sox2, Tdrd7, Mef2a,
and uncorrelated Myog across all samples utilized in this analysis
demonstrates the range of Oct4 expression in these samples and
also lends meaning at a biological level to the statistical analysis
performed (Figure 1).
GO Categorization of Oct4 Correlated Genes
In order to gain insight into the functions of Oct4 correlated
genes, GOstat analysis [24] was performed. As a result of this
analysis a number of gene ontology (GO) categories were found
to be correlated to Oct4 expression. Many over-represented terms
were related to transcription and DNA replication (nucleic acid
binding, DNA helicase, nucleolus), RNA processing (rRNA
processing, splicesome complex, and RNA splicing), and cellular
localization (nucleolus and Cajal body). Many under-represented
terms were related to inter-cellular communication (cell commu-
nication, receptor activity, signal transduction). A complete output
from GOstat is provided (Supplemental Table S3). Because this
method of analysis is highly dependent upon the GO categories
associated with a specific gene, the use of alternate GO databases
can result in divergent findings. Moreover, such analyses are
limited by the availability of databases which possess accurate
annotations that keep pace with current research.
To overcome these limitations, further refinement of GO
classifications for the Oct4 correlated genes was performed by
manual curation of a wide variety of databases such as NetAffx,
GeneCards, Ensembl, Stanford Source, Bioinformatics Harvester,a n d
PubMed (Supplemental Table S2). This analysis revealed that the
categories transcriptional regulation, intracellular signaling,
mRNA splicing, cell cycle, DNA repair, and chromatin were
highly represented within the positively Oct4 correlated genes.
Categories highly represented within the negatively correlated
genes included transcriptional regulation, protein modification,
transport, intracellular signaling, and apoptosis. A summary of
these findings is provided in Figure 2 with representative genes
in highly enriched categories provided in Table 1. Of note,
these findings are highly consistent with a previously published
GO analysis performed following Oct4 knockdown in hESC
[25].
Target Gene Validation
To validate our premise that this analysis would lead to the
identification of Oct4 direct transcriptional targets, we performed
a screen scanning the genomic region from 2 kb upstream of the
transcriptional start site to 2 kb downstream from the 3-prime
end of the transcribed region of the correlated genes for the
presence of neighboring Oct4 and dimerization partner Sox2
binding sites (Supplemental Material and Methods). As a result of
this analysis 392 genes were found to possess at least one putative
composite binding site (Supplemental Table S4) with several
genes such as Oct1/Pou2f1, Smyd3,a n dRanbp17 containing
Oct4 and Stem Cell Function
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reflect a requirement for strict regulatory control of these genes
throughout development. Although one might predict that genes
containing multiple binding sites would show a higher degree of
correlation to Oct4, a very cursory analysis of the data reveals that
this is in fact not the case. Genes containing 1 Oct4/Sox2 binding
site (and % correlation) are: Lig3 (+62), Kctd3 (+91), Bin1 (241),
Bmi1 (255), Nasp (99 and 79-two probesets). Genes containing
from 5 to 10 sites include: Insig2 (261), Ipo11 (+92), Myst4 (+94),
Nr6a1 (52 and 53) and Strbp (52). Genes with greater than 10 sites
are: Pou2f1 (+50), Ranbp17 (+99), and Smyd3 (+45).
Validation of 28 of these loci by chromatin immunoprecipita-
tion (ChIP) followed by quantitative real-time PCR (QRT-PCR)
confirmed the identification of 26 Oct4 direct transcriptional
targets (Figure 3; Supplemental Table S6). Notably, since the
completion of our studies, these findings have been confirmed by
several groups [11,12,25,26,27].
Further examination of these directly regulated target genes in
the context of the correlated gene-list reveals important insights
into how Oct4 regulates pivotal pathways involved in controlling
pluripotency, self-renewal and early lineage commitment.
Oct4 Correlated Genes are Implicated in Chromatin
Regulation
Recent experiments indicate that chromatin organization is
dynamic and is subject to regulatory mechanisms that enforce
the transcriptional potential of the genome during cellular
commitment and differentiation. Chromatin is remodeled into
transcriptionally permissive or repressive conformations by com-
plexes that covalently modify histones, act in an ATP-dependent
manner to reposition nucleosomes along DNA, or facilitate histone
exchange. Several complexes have been identified including SWI/
SNF, ISWI, INO80, and M1-2/CHD, and Trithorax group
(TrxG), and Polycomb group (PcG) proteins which mediate
chromatin remodeling by facilitating epigenetic modification of
histone tails to activate or repress gene expression, respectively
[28].
Thirty five genes implicated in chromatin remodeling were
correlated to Oct4. Putative positive target genes include SWI/
SNF members Smarcc1, AT rich interactive domain (Swi1 like)
containing proteins (ARID domains) Arid1a, Arid5b, Jarid1b and
Jarid2, which was confirmed as a direct Oct4 target. Notably, these
Figure 1. Oct4 Correlation Analysis. ESC, EC, myogenic, neuronal, retinal, and hematopoietic stem cells and their differentiated derivatives
underwent Affymetrix gene expression profiling as part of the Stem Cell Genomics Project. A set of 45 samples were profiled in biological triplicate
and hybridized to the MOE430 GeneChip set. Mean intensity values for each biological triplicate are plotted in log scale on the Y-axis, with an
approximate cutoff of 1000 demarcating detection status of each gene represented. Transcript expression levels of genes positively (Nanog, Sox2),
negatively (Tdrd7 and Mef2a), and not (Myog) correlated to Oct4 are displayed. Detection calls of ‘Present’ for Oct4 are depicted by solid black squares.
‘Absent’ calls are represented by open black squares.
doi:10.1371/journal.pone.0000553.g001
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family, have recently been associated with histone demethylase
activity [29]. Several other genes containing MYST, SET, and
CHROMO, and BROMO domains, which facilitate or recognize
specific histone modifications, were also identified.
Rest has been implicated in the repression of neuronal specific
genes via its ability to recruit cofactors such as histone deacetylases
(HDACs), Corest, Sin3, and Mecp2 [30]. The identification of Rest
as a direct Oct4 target, in light of its role in maintaining chromatin
plasticity throughout neurogenesis, [31] provides a mechanistic
understanding of Oct4’s role in promoting neural differentiation
[3]. Ironically, Rest has recently been described as both a tumor
suppressor [32] and an oncogene [33]. The identification of Corest
and Mecp2 as respectively positively and negatively correlated to
Oct4 may provide insight into the dynamic nature of Rest co-
repressor complexes throughout development that could explain
these seeming incongruities. Furthermore, this hypothesis is
supported by the recent description of the changing Rest-regulon
in the progression from embryonic stem cells to neural stem cells
(NSC) to differentiated neurons [34]
Importantly, several members of the TrxG and PcG of
transcription factors such as Ash1l, Suz12, Ash2l, Phc1, and
Rnf134, Bmi1, and Phc3 were correlated to Oct4, with the five
latter genes validated as Oct4 targets. Diverse functions for PcG
and TrxG genes in cancer, cell cycle control, and stem cell
function have recently been described [35,36,37,38]. The direct
transcriptional regulation of several members of these complexes
places Oct4 central to the coordination of these activities. The
localization of Suz12, a member of Polycomb Repressor Complex
2 (PRC2) at many Oct4 repressed loci in ESC [37,39] provides
indication that Oct4-Polycomb interaction may play a significant
role in the active repression of lineage. Furthermore, knock-down
Figure 2. Functional classification of Oct4 correlated genes. Manual curation of databases reveals highly enriched Gene Ontology (GO) categories
for Oct4 positively (A) and negatively (B) correlated genes. Numbers displayed represent percentage of unique transcripts attributed to each category
with only the most abundant categories listed individually.
doi:10.1371/journal.pone.0000553.g002
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PLoS ONE | www.plosone.org 4 June 2007 | Issue 6 | e553Figure 3. Validation of Oct4 targets. Chromatin immunoprecipitation (ChIP) assays were performed with Oct4 and IgG antibody and no antibody as
a negative control followed by Quantitative Real-time PCR analysis (ChIP/QRT-PCR) for putative positively regulated Oct4 target (A), negatively
regulated Oct4 target (B), and non-validated (C) genes. *8L16Rik represents 1110008L16Rik. Results are from two independent ChIP assays, with
duplicate QRT-PCR assessment for each. Error bars denote standard error of the mean (SEM).
doi:10.1371/journal.pone.0000553.g003
Table 1. Categories of Genes Identified as Oct4 Correlated.
..................................................................................................................................................
Chromatin Structure Nuclear Architecture DNA Repair Apoptosis Cell Cycle Control
Arid1a Pml Blm Aatf Anapc10
Arid5b Pum1 Brca1 Api5 Bub1
Ash1l Coil Chk1 Aven Ccna2
Ash2l Ncl Ddb1 Bag4 Ccnb1
Cdyl Mep50 Fancd2 Ciapin1 Ccnb2
Rest Nup54 Lig1 Commd10 Ccne1
Jarid1b Nup160 Lig3 Gtse1 Ccnf
Jarid2 Gemin4 Mre11a Opa1 Chfr
Nasp Gemin5 Msh2 Siva Cdk5rap3
Phc1 Sfrs2 Parp1 Spinl Cul2
Rnf134 Snrpn Rad17 Bin1 D14Abb1e
Setdb1 Snrpa Rad51 Blp1 Gstp1
Suz12 Snrpa1 Trp53 Serpinb9 Igf2bp1
Bmi1 Snurf Xrcc5 Sh3glb1 Jarid1b
Phc3 Sf3b14 Tdrd7 Casp6 Nipp1
Highly represented Gene Ontology categories as identified by manual curation of databases such as NetAFFX, GeneCards, Ensembl, Stanford Source, and Bioinformatics
Harvester and PubMed. Representative genes in each category are provided. Positively correlated genes are displayed in normal font. Negatively correlated genes are
displayed in bold italics.
doi:10.1371/journal.pone.0000553.t001
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PLoS ONE | www.plosone.org 5 June 2007 | Issue 6 | e553or overexpression of Oct4 has been shown to result in perturbed
expression of several members of PcG and TrxG that we have
identified as Oct4 targets and has led to loss of the pluripotent state
[26,27]. A comparison of the results of this study to the previous
studies can be found in Table 2. Taken together, these data
provide strong support for Oct4’s role in maintaining chromatin
structure in mESC via regulation of and interaction with a unique
constellation of PcG and TrxG complexes.
The negative correlation between Bmi1 and Oct4 was surprising
in light of its role in maintaining hematopoietic and neuronal stem
cells (HSCs, NSCs). Although necessary for self-renewal of HSCs
and NSCs, expression of Bmi1, which leads to chromatin
condensation and stable gene silencing [40] may be inconsistent
with self-renewal in pluripotent cells. Pluripotency involves the
ability to repress genes whose expression would result in a loss of
potential while retaining the ability to reawaken these transcrip-
tional programs upon differentiation. Therefore, while transcrip-
tional repression is necessary in both pluripotent cells and their
differentiated progeny, the means to accomplish it may, of
necessity, be entirely different.
PcGs exist as developmentally regulated multi-subunit com-
plexes [41]. Therefore it is predicted that alterations in the balance
of PcG members would have profound implications for mainte-
nance of the stem cell state. If, as anticipated above, inappropriate
upregulation of Bmi1 (and/or Phc3) leads to the repression of genes
that are required for pluripotency, this may ultimately be
manifested in a cell’s inability to differentiate and may provide
a partial explanation for the oncogenic roles of these proteins.
Table 2. Cross-Study Comparison of Oct4 Target Genes
..................................................................................................................................................
Gene Symbol
Campbell et al. Loh et al. [12] Boyer et al. [11] Ivanova et al. [26] Matoba et al. [27]
ChIP-PCR in mESC ChIP-PET in mESC ChIP-ChIP in hESC
Perturbed expression
following Oct4 shRNA
Perturbed Expression
following manipulation of
Oct4 expression (up or
down)
Phc1 33 - 33
Fgf4 3 --33
Utf1 3 --33
Nanog O/S 33 3 - 3
Jarid2 3 - 3 - 3
Hsf2bp 3 --33
Parp1 3 --- 3
D14Abb1e 3 --- 3
Aqr 3 --- -
Ccnf 3 --- 3
Sall4 3 --- 3
Igf2bp1 3 --- 3
Tdh 3 --33
Rest 33 3 33
Trp53 3 --- 3
Nanog 3 --- 3
Shmt1 3 --- 3
Ash2l 3 --- 3
Rnf134 3 --- -
Phb 3 --- 3
Brca1 3 --- 3
Tcf4 3 - 3 - 3
Rara 3 --33
Phc3 3 --- 3
Hoxb1 33 3 - 3
Bmi1 3 --- 3
Sh3glb1 3 --3 -
Tdrd7 3 --- -
Mef2a 3 --- -
Casp6 3 --33
Comparison of validated Oct4 targets to previous studies employing ChIP-Pet, ChIP-ChIP and expression analysis following Oct4 knockdown or overexpression.
Discordant findings in the ChIP based approaches may be explained by the use of promoter based chips or stringency of analysis. Although shRNA knockdown of Oct4
reveals few genes that are predicted to be bona fide Oct4 targets that are identified in common, comparison to the dataset in Matoba et el. [27] reveals that expression
of most of the targets identified in this study are in fact perturbed upon up or downregulation of Oct4. Discordant findings between this study and Matoba et al. may be
impacted by the temporal nature of Oct4 regulation of these target genes as has been described previously for the Rest regulon (Sun et al. [34]).
doi:10.1371/journal.pone.0000553.t002
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PLoS ONE | www.plosone.org 6 June 2007 | Issue 6 | e553Conversely, it is postulated that downregulation of other PcG
members such as Phc1 would result in the de-repression of genes
required for differentiation which would compromise self-renewal
[42].
Cell Cycle Control in Stem Cells Requires
Inactivation of pRb for Self-Renewal, Activation for
Differentiation
Carefully regulated execution of cell cycle progression is
accomplished in stem cells by a unique constellation of genes
which impact self-renewal and lineage commitment. Activation of
intracellular signaling pathways such as PI3K, Ras/Raf, and Jak/
Stat by molecular cues emanating from the stem cell niche mediate
phosphorylation events which control the activity of cyclin/CDK
complexes and culminate in the modulation of genes (such as pRb
and Trp53) that are implicated in cell cycle checkpoint, cell cycle
exit, and differentiation [43].
Assessment of GO terms revealed that 38 cell-cycle related
genes were positively correlated to Oct4 including Cdc25a, Gspt1,
Ppp1r8, Ccnb2, Ccne1, Ccna2, Ccnb1, and Ccnf. Validated Oct4
target Ccnf is implicated in cell cycle control at the G1/S and G2/
M checkpoints and has recently been associated with the
maintenance of pRb in a hyperphosphorylated, inactive state
[44]. The role of Ccnf in this process may in part be due to the E3
ubiquitin ligase domain of Ccnf to mediate the degradation of
phosphatases such as Pp1 involved in the sequential activation of
pRb through G1/S and G2/M [45]. Conversely, the significantly
Oct4 correlated (92%) Pp1 negative regulatory subunit Nipp1
(Ppp1r8) may facilitate the functional inactivation of pRb. This
hypothesis is consistent with the requirement of Nipp1 in early
embryonic development [46] and points toward a potential role
for Nipp1 in tumorigenesis [47]. In addition to its role in cell cycle
control is also involved in mRNA splicing, and transcriptional
repression through interactions with the PcG complexes making it
an important putative Oct4 target, capable of integrating the
diverse functions of cell cycle control, alternate splicing, chromatin
structure, and transcriptional regulation [46].
Based upon this analysis it is predicted that alterations in the
expression of Oct4 correlated genes such as Ccnf or Nipp1 that
impact the functional status of pRb (or pRb family member p107)
would have profound consequences. Inactivation of pRb is
required for self-renewal; activation of pRb is obligatory for cell
cycle exit and differentiation. An imbalance in either of these
processes, possibly emanating from deregulated signaling from the
stem cell niche or mutations in the key regulators would lead to
unrestrained cellular proliferation.
Genes Involved in Apoptosis and DNA Repair are
Correlated to Oct4 and are Implicated in Stem Cell
Differentiation
Prevailing thought holds that the initial stages of apoptosis involve
the caspase mediated induction of DNA strand breaks and either
the recruitment of DNA repair genes that act in concert to halt cell
cycle progression and restore genomic stability or, if the damage is
not able to be repaired, in further cleavage of DNA, nuclear
blebbing, and other processes which have been elegantly and
thoroughly described elsewhere that culminate in programmed
cell death. Both apoptosis and DNA repair are regulated by
several multi-component complexes with the roles of Trp53, Brca1,
and pRb being central to their coordination [48].
Analysis of the Oct4 gene list revealed an important emerging
theme; mechanisms to actively repress apoptotic pathways are
involved in maintaining the stem cell state. Twenty-five apoptotic
genes were positively correlated to Oct4, the majority of which,
including Aatf, Api5, Aven, Bag4, Commd10, Nipa, and Opa1, function
to inhibit apoptosis. In addition, Bin1, Blp1, Serpinb9, Sh3glb1, and
Casp6, all apoptosis inducing genes, were found to be negatively
correlated to Oct4, with Sh3glb1 and Casp6 confirmed as targets.
Thirty genes implicated in DNA damage and repair, were
positively correlated to Oct4. Members of the Brca1 associated
surveillance complex (BASC) including Brca1, Msh2, Mre11a,
Rad51, Blm, Chek1, as well as Parp1, Trp53, Fancd2, Tdrd7, and Xrcc5,
were included. The validation of Trp53, Tdrd7, Brca1, and Parp1 as
direct Oct4 targets strengthens the importance of this group of
genes in stem cell function.
The high frequency at which apoptotic genes were negatively
correlated to Oct4 and anti-apoptotic genes were positively
correlated to Oct4 implies that ‘anti-apoptosis’ is an important
theme for maintaining the stem cell state. Conversely, this may
also suggest that genes which modulate the initial response to
aberrant chromatin structure, apoptosis, and DNA repair, may
play important roles in lineage commitment. This notion is
consistent with the role of tudor domain containing proteins (such
as Tdrd7) in DNA damage response [49], Casp3 in skeletal muscle
differentiation [50], and the roles of Parp1 [51], Trp53 [52], and
Brca1[53] to modulate differentiation. Interestingly, a relationship
between DNA damage repair, chromatin remodeling [54], and
histone deacetylation [55], all previously implicated in cellular
differentiation, has recently been described. Moreover, knowledge
of the normal developmental functions of these genes in cellular
differentiation provides mechanistic insight into how these genes,
when mutated, lead to cancer.
Nuclear Architecture in Stem Cells Reinforces Their
Defining Characteristics
The nucleus is the site of many processes that profoundly impact
cellular phenotype including transcription, mRNA splicing, and
DNA replication and repair. Research has revealed that in fact
control of these activities is coordinated in a dynamic, spatio-
temporal manner. The presence of specific nuclear structures
(nuclear bodies; NBs), whose function is to concentrate key
regulatory molecules, mainly to loci of actively transcribed genes,
facilitates this coordination [56].
As a result of this analysis several key molecules whose presence
is indicative of NBs were observed. Pml and Coil (Cajal Bodies and
PML Bodies), Gemin4 and Gemin5 (Gems), Nup35, 43, 54, 98, 133,
160, 188 (Nuclear Pore Complex), Ncl and Nolc1 (Nucleolus) and
46 genes implicated in RNA metabolism (Splicing Speckles,
Spliceosome, Exosome, and Cajal Bodies) were positively
correlated to Oct4. Several genes implicated in nuclear transport
such as Ipo11, Kpna1, Tnpo2 and 3, Xpot, Gle1l, Xpo5 and 6 and
direct Oct4 targets Igf2bp1 and Phb were also positively correlated.
The incidence of nuclear bodies is incremental with cellular
proliferative capacity and their localization is predominately to
transcriptionally active regions of chromatin, although the
mechanisms that direct their localization are largely unknown.
Based upon the high degree of correlation of Oct4 to constituents of
NBs, it is conceivable that Oct4 target binding may function to
modulate the accessibility of local chromatin to these structures
and thereby enforce the transcriptional potential of specific genetic
loci in early development. The identification of Hoxb1 as
a negatively regulated Oct4 target is consistent with this hypothesis
in light of the recent finding that in ESCs Hoxb1, although not
expressed, is poised at the surface of its chromosome territory. In
the initial stages of differentiation Hoxb1 is transcriptionally
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ientation of this locus to the nuclear centre [57]. Together, these
findings lead us to predict that Oct4 binding functions not only in
the transcriptional repression of genes that would otherwise
facilitate lineage commitment, but also presents a means whereby
these loci are organized spatially within the nucleus so as to be
poised for activation given the appropriate cue.
In addition to the normal physiological roles for NBs described
above, they also play key roles in the response to DNA damage,
DNA repair, apoptosis, and senescence. Loss of regulation in the
recruitment and coordination of key genes contained in these
structures (Trp53, Pml, Brca1, Blm, etc.) would be predicted to have
profound implications in the ability of a cell to respond to signals
that would lead to differentiation. Such dysregulation is associated
with the accumulation of NBs at sites of DNA damage (DNA
damage induced foci) and is implicated in several types of cancer
such as acute promyelocytic leukemia (Pml-Rara translocation) and
Bloom’s Syndrome [56].
Conclusions
Through the use of gene expression data compiled from a vast
collection of adult and embryonic stem cells and their differen-
tiated derivatives we have performed a robust statistical analytic
method to identify genes that are correlated to Oct4. Although
several previous studies have mapped transcriptional targets of
Oct4, we believe that this study provides further insight into the
transcriptional regulatory networks, factors, and cofactors that
modulate stem cell function. Importantly, our experiments have
revealed hitherto unappreciated roles for Oct4 for firstly, regulating
chromatin structure in a state consistent with self-renewal and
pluripotency, and secondly, facilitating the expression of genes that
keeps the cell poised to respond to cues that lead to differentiation.
Furthermore, our analyses has led to the elucidation of themes that
are essential for maintaining ‘ES’ including permissive chromatin
structure, nuclear architecture, cell cycle control, apoptosis, and
DNA repair. Finally, we have identified 26 direct Oct4
transcriptional targets which may represent candidate regulatory
nodes by which cell fate decisions could be directed to facilitate the
use of hESCs in therapeutic and regenerative medicine (Figure 4A
and Table S2).
The Oct4 Transcriptional Regulatory Network
The expression of Oct4 in various forms of human cancer [8,9]
and a recently described role for Oct4 in adult stem cells [10] and
the expansion of epithelial progenitor cells [7] supports the theory
that cancer is a disease of stem cells. This theory postulates that
cancers arise in stem cells or early committed progenitors [58]
due to their inability to differentiate in a regulated fashion. Oct4
directly regulates the transcription of genes such as Trp53, Brca1,
Parp1, and Bmi1 which play a central role in a cell’s proclivity to
undergo transformation, apoptosis, senescence, and now differen-
tiation.
The process of development and the commitment to differen-
tiate is guided by the ordered expression and repression of genes
required to enforce specific transcriptional programs. Knowledge
of the emerging Oct4 transcriptional regulatory network provides
a means whereby we can begin to understand the molecular
mechanisms that guide these processes and gain insight into
aberrations that lead to disease. While the stem cell state is
guarded by highly dynamic, complex, and interrelated mech-
anisms which impact the repertoire, location, and functional state
of expressed genes, lineage commitment can be described as
a process whereby the unlimited ability for self-renewal and
potency are gradually restricted as a cell progresses from one
steady state of gene expression to the next. These diametrically
opposed states are mediated by a contrasted balance of forces that
impact chromatin structure, nuclear architecture, cell cycle, DNA
repair, and apoptosis (Figure 4B and C). Further examination of
the interactions among the genes identified as a result of this study
will provide a more thorough understanding of the pressures that
guide cell fate. Critically, only by understanding the normal
developmental function of a gene can we begin to understand the
role that it may play in disease. Importantly, our experiments have
defined how Oct4, as the master regulator of embryonic stem cell
function, plays a central role in regulating key genes in pivotal
pathways involved in controlling pluripotency, self-renewal and
differentiation.
MATERIALS AND METHODS
Stem Cell Culture and Isolation
The samples included in this study were obtained from various
members of the Stem Cell Network in support of The Stem Cell
Genomics Project. Full descriptions of the origin and experimental
conditions used to derive each sample can be obtained from
StemBase; (http://www.scgp.ca:8080/StemBase).
Target Labeling and Hybridization
Total RNA (10 ug or 10–50 ng) was labeled as per manufacturer’s
suggested methods (Afymetrix, Santa Clara, California, USA).
Briefly, following first strand and second strand cDNA synthesis,
samples underwent a single round (10 ug starting material) or two
rounds (10–50 ng starting material) of linear amplification using
a T7 based in vitro transcription (IVT) kit (MegascriptT7, Ambion).
During the final round of IVT, biotinylated nucleotides were
incorporated into the nascent strand (Enzo Biotech, Farmington,
Connecticut, USA) to produce the labeled target cRNA. Ten
micrograms of cRNA were fragmented to reduce complexity and
hybridized overnight to the MOE 430 GeneChip Set, according to
standard protocol. The GeneChips were then washed and stained
with Streptavidin R-Phycoerythrin (SAPE). Signal amplification
was accomplished by subsequent staining with biotinylated anti-
streptavidin, followed by an additional incubation with SAPE.
Scanning and absolute analysis was performed in MAS 5.0 to
generate the experiment (.exp), raw image (.dat), intensity (.cel)
and absolute analysis (.chp) files. All samples were scaled to a target
intensity of 1500 during analysis.
Correlation Analysis
Normalized expression values for each probeset were obtained
from MAS 5.0 (http://www.affymetrix.com/products/software/
specific/mas.affx) and the mean expression value for each set of
biological triplicates was calculated. The data were scaled by
normalizing to the trimmed mean for all probesets in the chips
(98%). Probesets that had a consensus detection call of present (P)
in more than 7% and less than 93% of the samples were included
in the analysis. The standard Pearson correlation coefficient (rho)
between every probeset which passed the filter, to the Oct4
probeset (1417945_at) was computed. A probeset is considered
correlated to Oct4 if the absolute value of rho is greater than or
equal to 0.75. This computation was repeated 10,000 times with
random subsets consisting of 65% to 70% of the data. Probesets
that were correlated in at least 40% of the trials were retained for
further analysis.
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GOstat (http://gostat.wehi.edu.au/) was used to examine selected
sets of probesets for over- and under-representation of GO terms,
using MGI (http://www.informatics.jax.org/mgihome/) as GO to
gene association database, and using false discovery rate
correction. This method is sensitive to the GO annotations
attached to the genes related to the probes, thus the result might
change if another database (e.g. GOA) is used.
Binding Site Analysis
The genomic region from 2 kb upstream of the transcriptional
start site to 2 kb downstream from the 3-prime end of the
transcribed region of the correlated genes was scanned for the
presence of neighboring Oct4 (ATGCAAAT) and Sox2 (AA-
CAAAG) binding sites. Global analysis of the Oct4 correlated gene-
list was performed in a conservative fashion based upon POU/
HMG/DNA ternary complex assembly as determined by crystal
structure assessment of Fgf4 and Utf1 [59]. First, the two
components of the Oct4 binding site, namely the POU specific
domain (POUS) and the POU homeodomain (POUH) were forced
to be consecutive in the sequence while independently in any
direction, and in any of the two strands. A perfect match was
required for POUS (ATGC), and one mismatch was allowed at
any of the four positions of POUH (AAAT). Second, we defined
the Sox2 binding site as either AACAAAG, which corresponds to
Figure 4. The Oct4 transcriptional regulatory network. Validated Oct4 targets (A) are indicated by solid red or green lines. Red and green indicate
negative and positive regulation, respectively for all cases. Dashed lines emanating from Oct4 indicate putatively regulated genes. Solid black lines
represent potential regulatory nodes that could facilitate the directed differentiation of ESCs. The pressures that preserve stem cell function and
modulate early lineage commitment are diametrically opposed. While Oct4 acts to maintain self-renewal and pluripotency in the undifferentiated ‘ES’
state by its modulation of genes that act to maintain permissive chromatin structure, DNA repair, anti-apoptosis, and inactive pRb (B), in
differentiation the balance of these forces is altered to favour repressive chromatin structure, DNA checkpoint control, apoptosis, and active pRB
which facilitate cellular commitment (C).
doi:10.1371/journal.pone.0000553.g004
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or AACAATG, in any direction or strand. The maximum distance
between Oct4 and Sox2 binding was constrained to 3 nucleotides.
Manual assessment of binding sites for a subset of the Oct4
correlated genes as well as developmentally important regulators
Hoxb1 and Tcf4 was performed in a less restrictive fashion. POUS
was held invariant while the POUH (AAAT) was allowed to vary
by one mismatch in any of the four nucleotide positions. Target
sequence identification for the two POU domains relative to each
other and to the Sox2 site were not restricted in order, orientation,
or strand. Finally, as has been observed for Oct4/Sox2 cooperative
binding on Opn [60], the distances between the Oct4 and Sox2
binding sites was relaxed and allowed to span up to 100
nucleotides.
Chromatin Immunoprecipitation
Chromatin Immunoprecipitation (ChIP) assays were performed
using the Chromatin Immunoprecipitation Assay Kit (Upstate
Biotechnology, Lake Placid, NJ, USA). Briefly, 5610
6 J1 ESCs
were cross-linked with 1% formaldehyde for 15 minutes at room
temperature. Cells were washed three times in ice-cold PBS with
protease inhibitors and lysed in buffer provided to which protease
inhibitors were also added. The cells were sonicated to an average
size of 1500 bp and 250 ug of input chromatin was used for each
assay. Immunoprecipitation was performed overnight at 4uC with
Oct4 antibody (Santa Cruz Biotechnology, Inc., Santa Cruz,
California) and no antibody as a negative control.
Quantitative Real-time PCR
Quantitative PCR was performed using primers that flanked the
regions containing putative Oct4 and Sox2 binding sites with the
MX4000 (Stratagene, La Jolla, California, USA) using iQ SYBR
Green Supermix (BioRad, Hercules, California.). The following
cycling parameters were employed: 96u 10 minutes, followed by
40 cycles of 96uC for 30 seconds, 57uC for 1 minute, and 72uC for
45 seconds. Primer sequences for each amplicon are described in
Supplemental Table S2. Each result represents two independent
ChIP assays with duplicate QRT-PCR analyses performed on
each target gene for each assay. 100% amplification efficiency is
assumed based on DDCt values of ,3.3 between each point of
a 10-fold serial dilution curve performed for a subset of the
amplicons. A 2-fold enrichment therefore represents the minimum
threshold for confirmation as an Oct4 target. Error bars denotes
the Standard Error of the Mean. Subsequent to QRT-PCR
analysis, each amplicon underwent DNA sequence analysis on and
ABI 3730 to confirm identity.
SUPPORTING INFORMATION
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